What is the Future of Clinical Phenotypes in Cancer?
The future of clinical phenotypes in cancer lies in the integration of advanced technologies such as next-generation sequencing, artificial intelligence, and liquid biopsies. These innovations promise to refine our understanding of cancer phenotypes, enabling even more precise and personalized treatment strategies. The ongoing research into the tumor microenvironment and its interaction with the immune system is also likely to uncover new phenotypic markers and therapeutic targets.
